Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 1:00 pm Purchase | 2025-12-31 | 13G | Aspire Biopharma Holdings, Inc. ASBP | ARDSLEY ADVISORY PARTNERS LP | 10,750,000 7.760% | 10,750,000 (New Position) | Filing History |
| 2025-05-19 8:30 pm Sale | 2025-05-06 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 55,197 4.520% | -41,613 (-42.98%) | Filing History |
| 2025-05-15 12:14 pm Purchase | 2025-03-31 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Harraden Circle Investments, LLC | 3,750 0.310% | 3,750 (New Position) | Filing History |
| 2025-05-07 5:15 pm Sale | 2025-04-29 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 96,810 7.920% | -4,084 (-4.05%) | Filing History |
| 2025-04-23 7:48 pm Sale | 2025-04-21 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 100,893 8.250% | -400 (-0.39%) | Filing History |
| 2025-04-17 4:22 pm Sale | 2025-04-11 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 101,293 8.280% | -3,291 (-3.15%) | Filing History |
| 2025-04-11 4:55 pm Sale | 2025-04-04 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 104,584 8.550% | -5,238 (-4.77%) | Filing History |
| 2025-04-04 5:28 pm Sale | 2025-03-26 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 109,822 8.980% | -1,163 (-1.05%) | Filing History |
| 2025-03-28 5:29 pm Sale | 2025-03-19 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 110,984 9.078% | -4,250 (-3.69%) | Filing History |
| 2025-03-20 9:58 pm Sale | 2025-03-03 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 115,234 9.462% | -4,875 (-4.06%) | Filing History |
| 2025-03-12 4:05 pm Sale | 2025-03-03 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 120,109 9.825% | -1,975 (-1.62%) | Filing History |
| 2025-02-26 9:20 pm Purchase | 2025-02-17 | 13G | Aspire Biopharma Holdings, Inc. ASBP | Lance Friedman | 122,084 9.980% | 122,084 (New Position) | Filing History |
| 2024-07-30 10:56 am Purchase | 2022-12-30 | 13G | PowerUp Acquisition Corp. PWUP | BANK OF NOVA SCOTIA | 692,168 2.400% | 692,168 (New Position) | Filing History |
| 2024-05-28 07:58 am Purchase | 2024-05-22 | 13G | PowerUp Acquisition Corp. PWUP | Harraden Circle Investments, LLC | 467,262 5.200% | 467,262 (New Position) | Filing History |
| 2024-02-14 09:33 am Sale | 2023-12-31 | 13G | PowerUp Acquisition Corp. PWUP | Glazer Capital, LLC | 30,639 0.340% | -2,204,656 (-98.63%) | Filing History |
| 2024-02-13 2:49 pm Sale | 2023-12-29 | 13G | PowerUp Acquisition Corp. PWUP | BANK OF NOVA SCOTIA | 0 0.000% | -1,551,375 (Position Closed) | Filing History |
| 2024-02-08 1:13 pm Sale | 2023-12-31 | 13G | PowerUp Acquisition Corp. PWUPU | Saba Capital Management, L.P. | 0 0.000% | -2,002,496 (Position Closed) | Filing History |
| 2024-02-07 07:18 am Unchanged | 2023-12-31 | 13G | PowerUp Acquisition Corp. PWUP | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-12-26 11:34 am Purchase | 2022-12-30 | 13G | PowerUp Acquisition Corp. PWUP | BANK OF NOVA SCOTIA | 1,551,375 5.400% | 1,551,375 (New Position) | Filing History |
| 2023-09-05 10:41 am Purchase | 2023-08-18 | 13D | PowerUp Acquisition Corp. PWUP | SRIRAMA Associates LLC | 4,317,500 48.000% | 4,317,500 (New Position) | Filing History |